Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Digoxin antibody

DIG ELISA Host: Mouse Monoclonal unconjugated
Catalog No. ABIN7212160
  • Target See all Digoxin (DIG) products
    Digoxin (DIG)
    Reactivity
    Please inquire
    Host
    • 38
    • 18
    • 2
    • 1
    • 1
    Mouse
    Clonality
    • 39
    • 21
    Monoclonal
    Conjugate
    • 22
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    This Digoxin antibody is un-conjugated
    Application
    • 26
    • 22
    • 9
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Purpose
    Digoxin Monoclonal Antibody
    Purification
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
    Immunogen
    Digoxin
    Isotype
    IgG1
  • Application Notes
    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: ELISA (1:10000). Not yet tested in other applications.
    Comment

    Primary Antibody

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
  • Target
    Digoxin (DIG)
    Alternative Name
    Digoxin (DIG Products)
    Target Type
    Chemical
    Background
    Mouse Anti-Digoxin Monoclonal Antibody,Digoxin,The most common indications for digoxin are atrial fibrillation and atrial flutter with rapid ventricular response, though beta blockers and/or calcium channel blockers are a better first choice. There is tentative evidence that digoxin may increase the risk of death, though another meta-analysis reports no change in mortality. High ventricular rate leads to insufficient diastolic filling time. By slowing down the conduction in the AV node and increasing its refractory period, digoxin can reduce the ventricular rate. The arrhythmia itself is not affected, but the pumping function of the heart improves, owing to improved filling.,Digoxin
You are here:
Support